Catalyst Wire Dossier Catalyst Wire Dossier

NMDA-enhancing agent

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for NMDA-enhancing agent, covering 2013-06-04 to 2013-06-04. Get the full timeline:

Most recent: Clinical Trial Update: NMDA-enhancing Agent for Treatment of Mild Cognitive Impairment and Mild Alzheimer's Disease [Phase 2]

See pricing